Antiviral compound protects nonhuman primates against Ebola virus
Tuesday, February 10, 2015 - 19:00
in Biology & Nature
Scientists protected 75 percent of rhesus monkeys infected with Ebola virus that were treated with a compound targeting the expression of VP24, a single Ebola virus protein--suggesting that VP24 may hold the key to developing effective therapies for the deadly disease.